Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1684/ejd.2023.4443 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Outcomes of androgenetic alopecia treated with dutasteride mesotherapy: A case series.
JAAD Case Rep
December 2024
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review.
Dermatology
December 2024
Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Background: Androgenetic alopecia (AGA) is a common skin disease characterized by gradually miniaturized hair follicles, which manifests as progressive hair thinning and produces a bald appearance. Currently, finasteride is approved by the Food and Drug Administration (FDA) for the treatment of AGA, but its efficacy remains poor in some patients.
Summary: Compared to finasteride, oral dutasteride has better efficacy and similar tolerability, and most adverse events are mild and reversible, making it an effective option for AGA, but its sexual adverse events and potential psychiatric risks still need to be concerned.
A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia.
J Cosmet Dermatol
October 2024
School of Pharmacy, BRAC University, Dhaka, Bangladesh.
Background: Oral finasteride and topical minoxidil formulations are the only FDA-approved drug therapies for androgenetic alopecia (AGA). Research into dutasteride, topical finasteride, and nontopical minoxidil (low-dose oral and sublingual) formulations in the treatment of AGA has spiked within recent years. Early findings show that these alternative drug therapies may have similar to improved efficacy and safety profiles relative to the conventional treatment options.
View Article and Find Full Text PDFSystematic review of mesotherapy: a novel avenue for the treatment of hair loss.
J Dermatolog Treat
December 2023
Dermatology Unit, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Italy.
Article Synopsis
- Mesotherapy is a procedure where lower doses of medication are injected into the skin to treat conditions like hair loss, allowing for longer-lasting effects and improved patient compliance.
- A systematic review analyzed 27 studies from a pool of 416 records to assess the effectiveness of mesotherapy for hair loss, focusing on various therapeutic agents used in treatment.
- While some studies indicate significant hair growth improvement from mesotherapy, the lack of standardized treatment protocols and potential side effects highlight the need for more extensive clinical trials.
Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects.
Dermatol Surg
September 2023
Department of Dermatology, The Ronald O. Perelman, NYU Grossman School of Medicine, New York, New York.
Background: Mesotherapy, a technique of transdermal microinjections of specific preparations, is increasingly used in fields such as dermatology and specifically for alopecia treatment. Its popularity stems from its ability to deliver drugs in a targeted manner while minimizing systemic side effects.
Objective: To assess and review current knowledge regarding the use of mesotherapy to deliver alopecia medications and highlight future directions for research.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!